Authors
Latest:
Medicare Part D Phase 2 Price Negotiations Target Semaglutide (Wegovy) Plus 14 More MedicationsPrice negotiations, effective in 2027, cover drugs for diabetes, cancer, COPD, and more, aiming for substantial Medicare savings.
Latest:
The Role for CGM in Glycemic Management Will Continue to Expand, Including in Prediabetes, Expert SaysCGM is now standard of care in T1D and evidence is solid for a role in insulin-treated T2D; Thomas Martens, MD, shares thoughts on CGM growth in the next 3-5 years.
Latest:
Importance of Patient Education and Multidisciplinary CommunicationPanelists discuss how proper application technique and adherence are vital for topical atopic dermatitis treatments. Effective provider communication and primary care provider/dermatologist collaboration optimize patient outcomes through education and coordinated care. Primary care providers and dermatologists should coordinate care through clear communication, shared protocols, and defined referral pathways to optimize atopic dermatitis management and improve patient outcomes.
Latest:
Improved Diabetes and Kidney Function Control With KidneyIntelXDrs Aide Vega and Fernando Carnavali highlight the increased control in both diabetes and kidney function with the use of KidneyIntelX in patients with DKD.
Latest:
What to Know Before AAD 2025: Product Snapshots of Nonsteroidal Topical Treatments for EczemaThey are a Janus kinase (JAK)1/JAK2 inhibitor, a phosphodiesterase-4 inhibitor, and an investigational aryl hydrocarbon receptor agonist. Learn more about each.
Latest:
Vaccines are Crucial for At-risk PopulationsIt is critical for physicians to urge patients with obesity to get vaccinated against COVID-19 as they are one of the highest risk patient populations.
Latest:
Antihistamines Are a Poor Option to Treat Eczema in Older Adults: Clinical PearlAntihistamines for itch caused by disorders like atopic dermatitis pose more problems, like sedation and fall risk, than they provide relief, according to Daniel Butler, MD.
Latest:
Elinzanetant Reduces Vasomotor Symptoms of Menopause Across BMI, Smoking StatusPooled data from the OASIS clinical trial program showed consistent efficacy of elinzanetant across BMI and smoking history subgroups, highlighting its broad applicability.
Latest:
Where Will the New Nonopioiod Suzetrigine (Journavx) Fit Best Along the Acute Pain Management Continuum? Phase 3 Investigator Shares ThoughtsSuzetrigine (Journavx) PI Todd Bertoch, MD, identifies the sweet spot where he thinks the new NaV1.8 inhibitor will be most effective in post-surgical and other moderate-to-severe acute pain.
Latest:
Role of Bempedoic Acid in Clinical PracticeExperts discuss key takeaways from the review article “Role of Bempedoic Acid in Clinical Practice”, clinical implications, and the greatly anticipated CLEAR Outcomes trial.
Latest:
How to Handle Medical Misinformation in the ClinicThese tips from a family physician on managing misinformation in the exam room can help reduce the spread of false and misleading narratives.
Latest:
Women's Heart Health: 5 Studies from ACC.25The risks to women's CV health differ, often significantly, from those faced by men, as demonstrated by 5 abstracts from the American College of Cardiology 2025 annual meeting.
Latest:
A Perioperative Pain Management Expert Scans His Crystal Ball for the Look of the Practice in 2050More consistent use of evidence-based guidelines and individualized pain management for every patient lead the hopes Edward Mariano, MD, MAS has for the future.
Latest:
To Fight Childhood Obesity, Use the Best Tools AvailableObesity affects nearly 20% of US children, impacting both current and future health. The 2020 update of the Pediatric Obesity Algorithm provides expert treatment guidance.
Latest:
Medical Students Augment Accurate Information During PandemicStudents from the Medical College of Georgia, unable to care directly for COVID-19 patients, combined their individual skills to keep accurate information flowing.
Latest:
First Biosimilar for Multiple Sclerosis Wins FDA ApprovalThe first biosimilar to the approved formulation of natalizumab is indicated for relapsing forms of MS and for induction/maintenance of remission in adults with Crohn disease.
Latest:
Mental Health & Cardiovascular Disease: What's the Link?What does the latest research say about the association between mental health and cardiovascular disease? Scroll through our quick slideshow for an overview.
Latest:
The Impact of Ozempic in the US: 3 Takeaways from a Recent SurveyNearly half of responding medical professionals said patients without T2D have asked for an Ozempic Rx and about 18% of them have provided one, avoiding significant backlash for a denial.
Latest:
Final Thoughts on Strategies for Managing and Monitoring Patients Receiving TeplizumabThe panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.
Latest:
Long COVID's Long Road: A Year 5 Update with Noah Greenspan DPT, PT, CCS, EMT-BFive years after the COVID-19 pandemic was declared, the protean syndrome dubbed long COVID continues to affect millions; Greenspan is dedicated to helping.
Latest:
How to Spot and Approach a Colleague in DistressMental health issues among health care professionals have always been normal; now that we can acknowledge them, we must, says a family physician and wellness advocate.
Latest:
Advances in Understanding of Itch: A Conversation with Brian S Kim, MD, MTR, at the 2025 AAD MeetingBrian S Kim, MD, a leading investigator in the study of itch physiology, discusses the marked progress made in understanding the sensation and targeting its treatment.
Latest:
Diabetes and Obesity: Why Obesity Treatment Should Come FirstAn obesity specialist explains why clinicians should start at the root cause when managing patients with type 2 diabetes and obesity.
Latest:
Obesity Management Demands Much More than MedicationObesity is a complex disease that requires a multispecialty approach to address the physical and also the mental and emotional components of the widespread disorder.
Latest:
Lexicon Receives Complete Response Letter for Sotagliflozin in Type 1 Diabetes and Chronic Kidney DiseaseIn November 2024, an FDA advisory committee said the benefits of sotagliflozin do not outweigh the risks in adults with type 1 diabetes and chronic kidney disease.
Latest:
Rethinking Lung Cancer Screening: Expanding Access for Women, NonsmokersACP 2025: Lung cancer is rising among nonsmokers, especially women. Kim Sandler, MD, discusses future screening challenges, research insights, and the need to expand screening eligibility.
Latest:
The System Isn’t Working for Americans with Kidney DiseaseToday, nearly 37 million Americans have chronic kidney disease (CKD), yet only about one percent of those Americans are even aware of their disease. And access to care is under threat.
